This webinar provides practical strategies for the analysis of complex genomic alterations such as co-occurring variants, splice-site mutations, and gene fusions.
View Webinar →
Presenters:
Shalini Verma, MD, FCAP - Medical Director and Laboratory Director, PierianDx
Andy Bredemeyer, PhD - VP of Product, PierianDx
View Webinar →
Learn about the benefits associated with integrating genomic medicine into clinical pathways, along with approaches for pilot programs and recommendations for developing a testing framework.
“Working with PierianDx has been an ideal partnership. They have been with us since the early onset of our program, providing both the technology and services that allowed us to ramp our program much faster.”
- Anthony Magliocco, MD - Chair, Anatomic Pathology, Moffitt Cancer Center
"I knew that with the resources we had, there was no way to create something that would rival a system like the CGW. As we've set up reflex testing in various cancer types, we have been well supported to scale the massive undertaking..."
- Nikoletta Sidiropoulos, MD - Medical Director, University of Vermont Medical Center
“There's going to be a bottleneck in the professional component as well sometimes. PierianDx allowed us to widen that bottleneck and to have more uniformity of reporting.”
- Eric Loo, MD - Asst. Professor, Pathology and Lab Medicine, Dartmouth-Hitchcock
“We chose PierianDx because their technology combined with expert scientific and clinical services will help accelerate TriCore’s ability to expand our NGS test offerings and provide enhanced clinically actionable information.”
- Eric Carbonneau - Director Core Laboratory Operations, TriCore Reference Laboratories
“A new partnership with PierianDx expands our reporting to include current clinical trials and up-to- the-minute treatment options, all linked to NorthShore’s Electronic Medical Record.”
- NorthShore University HealthSystem Kellogg Cancer Center 2017 Annual Report
6 City Place
Creve Coeur, MO 63141
314-628-0035
